ArticleThe Lancet regional health. Western Pacific2024

Improvements in the health-related quality-of-life benefit of cancer drugs approved in China, 2005-2020: an observational study.

Lan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.